论文部分内容阅读
目的:探讨消癌平注射液联合亚砷酸治疗中晚期肝癌的临床效果。方法:随机选取2010年10月-2014年10月佛山市龙江镇龙江医院收治的中晚期肝癌患者40例,分为对照组与观察组,每组20例,给予对照组亚砷酸注射液,观察组给予消癌平注射液联合亚砷酸治疗,对比治疗效果。结果:观察组患者病灶稳定率为75%;对照组患者病灶稳定率为35%,组间比较,差异具有统计学意义(P<0.05)。结论:在中晚期肝癌的治疗中,消癌平注射液联合亚砷酸的治疗效果显著。
Objective: To investigate the clinical effect of Xiaochangping injection combined with arsenious acid in the treatment of advanced liver cancer. Methods: Forty patients with advanced hepatocellular carcinoma admitted from Longjiang Hospital, Longjiang Town, Foshan City from October 2010 to October 2014 were randomly divided into control group and observation group, 20 cases in each group. Arsenious acid injection, The observation group given Xiaofangping injection combined with arsenic trioxide treatment, the treatment effect. Results: The stability of the lesion in the observation group was 75%. The stability of the lesion in the control group was 35%. There was significant difference between the two groups (P <0.05). Conclusion: In the treatment of advanced hepatocellular carcinoma, the therapeutic effect of Xiaojianping injection combined with arsenious acid is remarkable.